Skip to main content
Livermore
Livermore
ZHEN

Commonwealth Equity Services, LLC

SEC CIK
0000312272
Latest filing
Jul 29, 2026

CPRX holding history

Catalyst Pharmaceuticals, Inc. in every 13F filed by Commonwealth Equity Services, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CPRX overviewAll 13F holders of CPRXFull Q2 2026 holdings

Shares (Q2 2026)
37,949
Value
$1.19M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CPRX by Commonwealth Equity Services, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202637,949$1.19M<0.1%−11,432−23.2%ReducedHolders
Q1 202649,381$1.22M<0.1%+33,301+207.1%AddedHolders
Q4 202516,080$375.3K<0.1%+927+6.1%AddedHolders
Q3 202515,153$299.0K<0.1%−22,549−59.8%ReducedHolders
Q2 202537,702$818.0K<0.1%−3,873−9.3%ReducedHolders
Q1 202541,575$1.01M<0.1%+2,244+5.7%AddedHolders
Q4 202439,331$821.0K<0.1%+22,455+133.1%AddedHolders
Q3 202416,876$335.0K<0.1%−2,023−10.7%ReducedHolders
Q2 202418,899$293.0K<0.1%−684−3.5%ReducedHolders
Q1 202419,583$312.0K<0.1%−638−3.2%ReducedHolders
Q4 202320,221$340.0K<0.1%+3,041+17.7%AddedHolders
Q3 202317,180$201.0K<0.1%−6,824−28.4%ReducedHolders
Q2 202324,004$323.0K<0.1%+3,360+16.3%AddedHolders
Q1 202320,644$342.0K<0.1%+408+2.0%AddedHolders
Q4 202220,236$376.0K<0.1%+4,318+27.1%AddedHolders
Q3 202215,918$204.0K<0.1%+2,233+16.3%AddedHolders
Q2 202213,685$95.0K<0.1%+2,885+26.7%AddedHolders
Q1 202210,800$89.0K<0.1%−2,055−16.0%ReducedHolders
Q4 202112,855$87.0K<0.1%+641+5.2%AddedHolders
Q3 202112,214$64.0K<0.1%+1,158+10.5%AddedHolders
Q2 202111,056$63.0K<0.1%00.0%UnchangedHolders
Q1 202111,056$50.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.